ABSTRACT Undernutrition and infections during pregnancy result in low birth weight (LBW) and maternal anaemia. Social behaviour change communication (SBCC) can promote recommended health practices, potentially improving maternal and neonatal outcomes.
Wanzahun Godana Boynito +9 more
wiley +1 more source
Partial response to posterior line immunotherapy for more than 15 months in a pMMR patient with cutaneous metastasis of rectal carcinoma: a case report. [PDF]
Li JJ, Xu PF, Nie YL.
europepmc +1 more source
Visual–spatial abilities enhancement and spatial anatomy learning: A systematic review
Abstract Introduction Student's visual–spatial abilities appear to be an important predictor of learning time, performance and knowledge in anatomy. The objective of this systematic review was to assess the relationship between spatial abilities enhancement and spatial learning of anatomy.
Lara Nokovitch +5 more
wiley +1 more source
Case Series and Literature Review on Phenotypic Variants of Restless Legs Syndrome (RLS): A Unique Phase of Typical RLS? [PDF]
Zhang X +6 more
europepmc +1 more source
Pelvic and Perineal Reconstruction After Bowel, Gynecological or Sacral Tumor Resection: A Case Series. [PDF]
Bini A, Stavrianos S.
europepmc +1 more source
Necrotizing Fasciitis of the Labia Caused by Beta-Hemolytic Streptococcus and Streptococcus Anginosus: A Case Report and Literature Review. [PDF]
Bowens Z +4 more
europepmc +1 more source
The long‐term anorectal outcomes of non‐surgically treated patients diagnosed with minor types of ARM seem optimal. Most of these patients experience no constipation or fecal incontinence; some experience constipation and relatively seldom fecal incontinence. Furthermore, most patients possess all the known fecal continence mechanisms.
Venla E. C. den Hollander +3 more
wiley +1 more source
Birth and Regulation of head Extension to Guide Manual perineal Assistance (BREGMA) study: a prospective cohort study. [PDF]
Abouelhassan A +5 more
europepmc +1 more source
ABSTRACT Two 4‐week, phase 2, open‐label, maximal usage pharmacokinetic (PK) and safety studies of once‐daily roflumilast cream 0.3% (a potent phosphodiesterase 4 inhibitor) were conducted in children aged 2–5 years and 6–11 years with psoriasis. Evidence of systemic exposure to roflumilast and its active N‐oxide metabolite was seen in most patients ...
Adelaide A. Hebert +13 more
wiley +1 more source

